News | NICE

New option for people with difficult-to-treat multiple myeloma is recommended for use in Cancer Drugs Fund by NICE

Around 5,700 cases of multiple myeloma are diagnosed each year in the UK

Read news story

NICE is getting ready for the end of the transition period after Brexit

NICE has a key role in evaluation and access to new and innovative products for the health system, playing an important role in ensuring the UK remains a destination of choice for the life sciences sector.

19 November 2020
NICE recommends innovative treatment for severe blood disorder for NHS use

Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.

12 November 2020
NICE recommends new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemia

More than 1,000 people each year will benefit from NICE's recommendation

10 November 2020

Blogs

How NICE is improving patient safety
25 November 2020
World Antimicrobial Awareness Week: developing new models for the evaluation and purchase of antimicrobials
18 November 2020
How NICE guidance and resources can be used to evidence continuing professional development (CPD)
12 November 2020
Shared Learning Awards 2020 finalist: Bronchiolitis: when less is more
04 November 2020

Events

NICE Annual Conference

13 May 2021, Hilton Manchester Deansgate

Due to the ongoing COVID-19 pandemic, we have decided to postpone our annual conference from November 2020 until May 2021.

For further information, please visit the conference website.

NICE Talks Podcasts

NICE Talks brings you the real-life experiences of people working within the NHS, public health and social care.

You will hear the stories behind our work to improve care across the country through evidence-based guidance.

Press and media

Contact the press office: 0300 323 0142 | pressoffice@nice.org.uk